PTX 0.00% 4.1¢ prescient therapeutics limited

Ann: Investor Presentation, page-14

  1. 417 Posts.
    lightbulb Created with Sketch. 115
    Hey guys just in regards to the presentation. A lot of it is the same to most of us here, but I did notice that on the “catalyst roadmap” they have changed the “Dose escalation for PTX-200 Ph1b AML trial (Q12022)” to “Results for PTX-200 Ph1b AML trial (Q2 2022)”
    This has changed since the webinar on the 16/2/22.
    only a small detail but just wanted to point it out smile.png
    https://hotcopper.com.au/data/attachments/4130/4130731-3dc7d28e47e00f2827ee14547229b7d3.jpg

 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.